公司資料
BioLife Solutions 股價、新聞與催化劑
- 股票代碼:
- BLFS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
35.45 USD (+1.08%)
收盤價
最後更新: 2026年8月17日
1.34B USD
市值
股價為何變動
As of Aug 17, 2026, BLFS closed up 1.08% at $35.45. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
BioLife Solutions is a life-sciences tools company focused on biopreservation, storage, and cryogenic logistics for cell and gene therapy workflows. Its products support the manufacturing and handling side of advanced therapies.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, BioLife sits in biotech infrastructure.
商業模式特徵
Revenue comes from consumables, storage systems, and workflow tools used by advanced-therapy developers.
生技產業定位
BioLife is an enabling platform name whose value tracks cell and gene therapy infrastructure spending.
未來催化劑
- BioLife Solutions's catalysts are cryopreservation demand and cell-therapy workflow growth, both of which depend on whether the broader cell-therapy market keeps recovering. The company can improve quickly if cell therapy activity really normalizes.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。